|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
372 a.a.
|
 |
|
|
|
|
|
|
|
158 a.a.
|
 |
|
|
|
|
|
|
|
165 a.a.
|
 |
|
|
|
|
|
|
|
11 a.a.
|
 |
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/isomerase/immunosuppressant
|
 |
|
Title:
|
 |
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes
|
|
Structure:
|
 |
Serine/threonine protein phosphatase 2b catalytic subunit, alpha isoform. Chain: a, e. Fragment: residues 1-372. Synonym: calmodulin-dependent calineurin a subunit, alpha isoform, cam-prp subunit. Engineered: yes. Calcineurin b subunit isoform 1. Chain: b, f.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: cna alpha. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Gene: cnb. Synthetic: yes. Tolypocladium inflatum.
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.260
|
R-free:
|
0.322
|
|
|
Authors:
|
 |
Q.Huai,H.-Y.Kim,Y.Liu,Y.Zhao,A.Mondragon,J.O.Liu,H.Ke
|
Key ref:
|
 |
Q.Huai
et al.
(2002).
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes.
Proc Natl Acad Sci U S A,
99,
12037-12042.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
12-Jul-02
|
Release date:
|
25-Sep-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q08209
(PP2BA_HUMAN) -
Protein phosphatase 3 catalytic subunit alpha from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
521 a.a.
372 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
P63098
(CANB1_HUMAN) -
Calcineurin subunit B type 1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
170 a.a.
158 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
Chains A, E:
E.C.3.1.3.16
- protein-serine/threonine phosphatase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate
|
|
2.
|
O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate
|
|
 |
 |
 |
 |
 |
O-phospho-L-seryl-[protein]
|
+
|
H2O
|
=
|
L-seryl-[protein]
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
O-phospho-L-threonyl-[protein]
|
+
|
H2O
|
=
|
L-threonyl-[protein]
|
+
|
phosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
Chains C, G:
E.C.5.2.1.8
- peptidylprolyl isomerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[protein]-peptidylproline (omega=180) = [protein]-peptidylproline (omega=0)
|
 |
 |
 |
 |
 |
Peptidylproline (omega=180)
|
=
|
peptidylproline (omega=0)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
99:12037-12042
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes.
|
|
Q.Huai,
H.Y.Kim,
Y.Liu,
Y.Zhao,
A.Mondragon,
J.O.Liu,
H.Ke.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Calcineurin, a Ca2+/calmodulin-dependent protein phosphatase, is the common
target for two immunophilin-immunosuppressant complexes, cyclophilin
A-cyclosporin A (CyPA-CsA) and FKBP-FK506. How the two structurally distinct
immunophilin-drug complexes bind the same target has remained unknown. We report
the crystal structure of calcineurin (CN) in complex with CyPA-CsA at 2.8-A
resolution. The CyPA-CsA complex binds to a composite surface formed by the
catalytic and regulatory subunits of CN, where the complex of FK506 and its
binding protein FKBP also binds. While the majority of the CN residues involved
in the binding are common for both immunophilin-immunosuppressant complexes, a
significant number of the residues are distinct. Unlike FKBP-FK506, CyPA-CsA
interacts with Arg-122 at the active site of CN, implying direct involvement of
CyPA-CsA in the regulation of CN catalysis. The simultaneous interaction of CyPA
with both the composite surface and the active site of CN suggests that the
composite surface may serve as a substrate recognition site responsible for the
narrow substrate specificity of CN. The comparison of CyPA-CsA-CN with
FKBP-FK506-CN significantly contributes to understanding the molecular basis of
regulation of CN activity by the immunophilin-immunosuppressant.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Fig 2. Ribbon representation of CyPA-CsA-CN. Color codes
are CNA, gold; CNB, cyan; CsA, green; CyPA, red; Zn2+ and Fe^3+,
pink; and calcium, blue. The residues from CN involved in
binding of CyPA-CsA are shown as blue balls.
|
 |
Figure 4.
Fig 4. Interfacial interactions between CN and
immunophilins-immunosuppressants. CNA and CNB are shown as
yellow and cyan ribbons. (A) The CN composite surface for
CyPA-CsA binding. A total of 25 residues of CN are involved in
interaction with CyPA-CsA: Arg-122, Tyr-159, Phe-160, Leu-312,
Val-314, Tyr-315, Tyr-341, Trp-342, Pro-344, Asn-345, Trp-352,
Ser-353, Pro-355, Phe-356, and Glu-359 of CNA, and Glu-47,
Gln-50, Met-118, Val-119, Asn-122, Leu-123, Lys-124, and Lys-164
of CNB. Red balls represent residues interacting with CyPA and
green balls represent residues interacting with CsA (green
sticks). The residues from CNB are marked with the letter "B"
attached to the residue number. (B) The CN surface for binding
of CyPA-CsA and FKBP12-FK506. CN residues in red interact with
both CyPA-CsA and FKBP12-FK506. Green residues are unique for
CyPA-CsA binding and blue residues are unique for FKBP-FK506.
CsA and FK506 are shown as green and blue sticks. (C) CyPA
residues for recognition of CN (gold) and CsA (blue). CsA is
shown in green sticks.
|
 |
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
Y.Pommier,
and
C.Marchand
(2012).
Interfacial inhibitors: targeting macromolecular complexes.
|
| |
Nat Rev Drug Discov,
11,
25-36.
|
 |
|
|
|
|
 |
A.Kuglstatter,
F.Mueller,
E.Kusznir,
B.Gsell,
M.Stihle,
R.Thoma,
J.Benz,
L.Aspeslet,
D.Freitag,
and
M.Hennig
(2011).
Structural basis for the cyclophilin A binding affinity and immunosuppressive potency of E-ISA247 (voclosporin).
|
| |
Acta Crystallogr D Biol Crystallogr,
67,
119-123.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Li,
A.Rao,
and
P.G.Hogan
(2011).
Interaction of calcineurin with substrates and targeting proteins.
|
| |
Trends Cell Biol,
21,
91.
|
 |
|
|
|
|
 |
R.W.Niven
(2011).
Toward managing chronic rejection after lung transplant: the fate and effects of inhaled cyclosporine in a complex environment.
|
| |
Adv Drug Deliv Rev,
63,
88.
|
 |
|
|
|
|
 |
S.R.Pereira,
V.T.Vasconcelos,
and
A.Antunes
(2011).
The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins.
|
| |
Crit Rev Toxicol,
41,
83.
|
 |
|
|
|
|
 |
A.Galat,
and
J.Bua
(2010).
Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.
|
| |
Cell Mol Life Sci,
67,
3467-3488.
|
 |
|
|
|
|
 |
Q.Chen,
W.Wu,
J.Li,
and
Q.Wei
(2010).
The polarity of the amino acid residue 118 of calcineurin B is closely linked to calcineurin enzyme activity.
|
| |
IUBMB Life,
62,
561-567.
|
 |
|
|
|
|
 |
Y.Amasaki
(2010).
[Calcineurin inhibitors and calcineurin-NFAT system].
|
| |
Nihon Rinsho Meneki Gakkai Kaishi,
33,
249-261.
|
 |
|
|
|
|
 |
Z.Li,
W.Min,
C.Huang,
S.Bai,
M.Tang,
and
X.Zhao
(2010).
Proteomics-based approach identified differentially expressed proteins with potential roles in endometrial carcinoma.
|
| |
Int J Gynecol Cancer,
20,
9.
|
 |
|
|
|
|
 |
A.Agbas,
and
J.Moskovitz
(2009).
The Role of Methionine Oxidation/Reduction in the Regulation of Immune Response.
|
| |
Curr Signal Transduct Ther,
4,
46-50.
|
 |
|
|
|
|
 |
A.Rodríguez,
J.Roy,
S.Martínez-Martínez,
M.D.López-Maderuelo,
P.Niño-Moreno,
L.Ortí,
D.Pantoja-Uceda,
A.Pineda-Lucena,
M.S.Cyert,
and
J.M.Redondo
(2009).
A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants.
|
| |
Mol Cell,
33,
616-626.
|
 |
|
|
|
|
 |
B.De Angelis,
G.Dotti,
C.Quintarelli,
L.E.Huye,
L.Zhang,
M.Zhang,
F.Pane,
H.E.Heslop,
M.K.Brenner,
C.M.Rooney,
and
B.Savoldo
(2009).
Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).
|
| |
Blood,
114,
4784-4791.
|
 |
|
|
|
|
 |
J.L.McConnell,
and
B.E.Wadzinski
(2009).
Targeting protein serine/threonine phosphatases for drug development.
|
| |
Mol Pharmacol,
75,
1249-1261.
|
 |
|
|
|
|
 |
J.O.Liu
(2009).
Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation.
|
| |
Immunol Rev,
228,
184-198.
|
 |
|
|
|
|
 |
K.Gauwerky,
C.Borelli,
and
H.C.Korting
(2009).
Targeting virulence: a new paradigm for antifungals.
|
| |
Drug Discov Today,
14,
214-222.
|
 |
|
|
|
|
 |
M.Sieber,
and
R.Baumgrass
(2009).
Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506?
|
| |
Cell Commun Signal,
7,
25.
|
 |
|
|
|
|
 |
Y.Ren,
Z.X.Wang,
and
Q.Wei
(2009).
Mechanism of activation of Saccharomyces cerevisiae calcineurin by Mn2+.
|
| |
Biol Chem,
390,
1155-1162.
|
 |
|
|
|
|
 |
Y.Shi
(2009).
Serine/threonine phosphatases: mechanism through structure.
|
| |
Cell,
139,
468-484.
|
 |
|
|
|
|
 |
Y.Zhang,
F.Erdmann,
and
G.Fischer
(2009).
Augmented photoswitching modulates immune signaling.
|
| |
Nat Chem Biol,
5,
724-726.
|
 |
|
|
|
|
 |
Q.Ye,
H.Wang,
J.Zheng,
Q.Wei,
and
Z.Jia
(2008).
The complex structure of calmodulin bound to a calcineurin peptide.
|
| |
Proteins,
73,
19-27.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.G.Ptak,
P.A.Gallay,
D.Jochmans,
A.P.Halestrap,
U.T.Ruegg,
L.A.Pallansch,
M.D.Bobardt,
M.P.de Béthune,
J.Neyts,
E.De Clercq,
J.M.Dumont,
P.Scalfaro,
K.Besseghir,
R.M.Wenger,
and
B.Rosenwirth
(2008).
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
|
| |
Antimicrob Agents Chemother,
52,
1302-1317.
|
 |
|
|
|
|
 |
J.Luban
(2007).
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.
|
| |
J Virol,
81,
1054-1061.
|
 |
|
|
|
|
 |
K.Takeuchi,
M.H.Roehrl,
Z.Y.Sun,
and
G.Wagner
(2007).
Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.
|
| |
Structure,
15,
587-597.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Sieber,
M.Karanik,
C.Brandt,
C.Blex,
M.Podtschaske,
F.Erdmann,
R.Rost,
E.Serfling,
J.Liebscher,
M.Pätzel,
A.Radbruch,
G.Fischer,
and
R.Baumgrass
(2007).
Inhibition of calcineurin-NFAT signaling by the pyrazolopyrimidine compound NCI3.
|
| |
Eur J Immunol,
37,
2617-2626.
|
 |
|
|
|
|
 |
V.Venugopal,
B.Sen,
A.K.Datta,
and
R.Banerjee
(2007).
Structure of cyclophilin from Leishmania donovani at 1.97 A resolution.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
63,
60-64.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.J.Steinbach,
J.L.Reedy,
R.A.Cramer,
J.R.Perfect,
and
J.Heitman
(2007).
Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections.
|
| |
Nat Rev Microbiol,
5,
418-430.
|
 |
|
|
|
|
 |
X.Ai,
L.Li,
A.Semesi,
A.Yee,
C.H.Arrowsmith,
S.S.Li,
and
W.Y.Choy
(2007).
Hypothetical protein AF2241 from Archaeoglobus fulgidus adopts a cyclophilin-like fold.
|
| |
J Biomol NMR,
38,
353-358.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Marchand,
S.Antony,
K.W.Kohn,
M.Cushman,
A.Ioanoviciu,
B.L.Staker,
A.B.Burgin,
L.Stewart,
and
Y.Pommier
(2006).
A novel norindenoisoquinoline structure reveals a common interfacial inhibitor paradigm for ternary trapping of the topoisomerase I-DNA covalent complex.
|
| |
Mol Cancer Ther,
5,
287-295.
|
 |
|
|
|
|
 |
D.J.Loane,
G.A.Hicks,
B.A.Perrino,
and
N.V.Marrion
(2006).
Inhibition of BK channel activity by association with calcineurin in rat brain.
|
| |
Eur J Neurosci,
24,
433-441.
|
 |
|
|
|
|
 |
K.K.Jin,
S.S.Krishna,
R.Schwarzenbacher,
D.McMullan,
P.Abdubek,
S.Agarwalla,
E.Ambing,
H.Axelrod,
J.M.Canaves,
H.J.Chiu,
A.M.Deacon,
M.DiDonato,
M.A.Elsliger,
J.Feuerhelm,
A.Godzik,
C.Grittini,
S.K.Grzechnik,
J.Hale,
E.Hampton,
J.Haugen,
M.Hornsby,
L.Jaroszewski,
H.E.Klock,
M.W.Knuth,
E.Koesema,
A.Kreusch,
P.Kuhn,
S.A.Lesley,
M.D.Miller,
K.Moy,
E.Nigoghossian,
L.Okach,
S.Oommachen,
J.Paulsen,
K.Quijano,
R.Reyes,
C.Rife,
R.C.Stevens,
G.Spraggon,
H.van den Bedem,
J.Velasquez,
A.White,
G.Wolf,
G.W.Han,
Q.Xu,
K.O.Hodgson,
J.Wooley,
and
I.A.Wilson
(2006).
Crystal structure of TM1367 from Thermotoga maritima at 1.90 A resolution reveals an atypical member of the cyclophilin (peptidylprolyl isomerase) fold.
|
| |
Proteins,
63,
1112-1118.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.B.Koefoed-Nielsen,
N.Karamperis,
C.Højskov,
J.H.Poulsen,
and
K.A.Jørgensen
(2006).
The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients.
|
| |
Transpl Int,
19,
821-827.
|
 |
|
|
|
|
 |
B.Adams,
A.Musiyenko,
R.Kumar,
and
S.Barik
(2005).
A novel class of dual-family immunophilins.
|
| |
J Biol Chem,
280,
24308-24314.
|
 |
|
|
|
|
 |
B.Chan,
G.Greenan,
F.McKeon,
and
T.Ellenberger
(2005).
Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
|
| |
Proc Natl Acad Sci U S A,
102,
13075-13080.
|
 |
|
|
|
|
 |
J.R.Blankenship,
and
J.Heitman
(2005).
Calcineurin is required for Candida albicans to survive calcium stress in serum.
|
| |
Infect Immun,
73,
5767-5774.
|
 |
|
|
|
|
 |
L.Berthoux,
S.Sebastian,
E.Sokolskaja,
and
J.Luban
(2005).
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
|
| |
Proc Natl Acad Sci U S A,
102,
14849-14853.
|
 |
|
|
|
|
 |
P.Wang,
and
J.Heitman
(2005).
The cyclophilins.
|
| |
Genome Biol,
6,
226.
|
 |
|
|
|
|
 |
Y.Pommier,
and
J.Cherfils
(2005).
Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery.
|
| |
Trends Pharmacol Sci,
26,
138-145.
|
 |
|
|
|
|
 |
A.R.Hamel,
F.Hubler,
A.Carrupt,
R.M.Wenger,
and
M.Mutter
(2004).
Cyclosporin A prodrugs: design, synthesis and biophysical properties.
|
| |
J Pept Res,
63,
147-154.
|
 |
|
|
|
|
 |
R.Kumar,
A.Musiyenko,
A.Oldenburg,
B.Adams,
and
S.Barik
(2004).
Post-translational generation of constitutively active cores from larger phosphatases in the malaria parasite, Plasmodium falciparum: implications for proteomics.
|
| |
BMC Mol Biol,
5,
6.
|
 |
|
|
|
|
 |
Y.Zhang,
R.Baumgrass,
R.Raumgrass,
M.Schutkowski,
and
G.Fischer
(2004).
Branches on the alpha-C atom of cyclosporin A residue 3 result in direct calcineurin inhibition and rapid cyclophilin 18 binding.
|
| |
Chembiochem,
5,
1006-1009.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |